11,374 Shares in Cardinal Health, Inc. $CAH Acquired by Counterpoint Mutual Funds LLC

Key Points

• Counterpoint Mutual Funds LLC acquired 11,374 shares of Cardinal Health, valued at approximately $1.91 million, during the second quarter.
• Cardinal Health's CEO, Jason M. Hollar, sold 35,901 shares worth about $5.39 million, reducing his ownership by 15.22%.
• The company's stock has a consensus rating of "Moderate Buy" with a price target of $165.93, despite a recent downgrade from Wall Street analysts.

Counterpoint Mutual Funds LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,374 shares of the company's stock, valued at approximately $1,911,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CAH. Greykasell Wealth Strategies Inc. bought a new position in Cardinal Health during the first quarter valued at about $26,000. Tompkins Financial Corp boosted its stake in Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after buying an additional 128 shares in the last quarter. GW&K Investment Management LLC boosted its stake in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after buying an additional 144 shares in the last quarter. NBC Securities Inc. bought a new position in Cardinal Health during the first quarter valued at about $48,000. Finally, Zions Bancorporation National Association UT bought a new position in Cardinal Health during the first quarter valued at about $52,000. Institutional investors own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

CAH has been the subject of several research reports. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Leerink Partners decreased their price target on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research report on Tuesday, August 12th. Morgan Stanley restated an "overweight" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Argus set a $189.00 price target on shares of Cardinal Health in a research report on Friday, August 22nd. Finally, Bank of America lifted their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $165.93.

Insider Transactions at Cardinal Health

In related news, CEO Jason M. Hollar sold 35,901 shares of the company's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares in the company, valued at approximately $30,008,000. This represents a 15.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Michelle D. Greene sold 13,500 shares of the company's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares of the company's stock, valued at $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock valued at $40,489,525 in the last three months. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Stock Down 1.3%

Shares of NYSE:CAH opened at $147.61 on Tuesday. The firm has a fifty day moving average of $152.78 and a two-hundred day moving average of $148.84. The firm has a market capitalization of $35.07 billion, a P/E ratio of 22.89, a price-to-earnings-growth ratio of 1.27 and a beta of 0.73. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company's revenue for the quarter was up .5% on a year-over-year basis. During the same quarter last year, the business posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health's dividend payout ratio is currently 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.